Patient Guide: A Study to Compare the Blood Levels and Safety of Tazemetostat in Participants With Advanced Cancer and Moderate/Severe Liver Impairment to Participants With Advanced Cancer and Normal Liver Function

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 18 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04241835
Status: 🟢 Enrolling Now
Condition: Hepatic Impairment, Advanced Malignant Solid Tumor
Phase: PHASE1

Where You Can Participate

This study is available at 18 locations across the country.

Top locations include:
  • • Lake Mary, Florida
  • • Chicago, Illinois
  • • Royal Oak, Michigan
  • • And 15 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Compare the Blood Levels and Safety of Tazemetostat in Participants With Advanced Cancer and Moderate/Severe Liver Impairment to Participants With Advanced Cancer and Normal Liver Function - Join Clinical Trial NCTNCT04241835

How to Join This Clinical Trial - NCTNCT04241835

Learn how to participate in this PHASE1 trial studying an investigational therapy for Hepatic Impairment, Advanced Malignant Solid Tumor. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Hepatic Impairment, Advanced Malignant Solid Tumor. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Hepatic Impairment, Advanced Malignant Solid Tumor
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT04241835 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 18 locations. Find a study site near you:

Clinical Research Site

Lake Mary, Florida 32746 - United States

Status: COMPLETED

Clinical Research Site

Chicago, Illinois 60611 - United States

Status: COMPLETED

Clinical Research Site

Royal Oak, Michigan 48073 - United States

Status: COMPLETED

Clinical Research Site

Las Vegas, Nevada 89014 - United States

Status: COMPLETED

Clinical Research Site

New Brunswick, New Jersey 08901 - United States

Status: RECRUITING

Clinical Research Site

Canton, Ohio 44718 - United States

Status: COMPLETED

Clinical Research Site

Dallas, Texas 75230 - United States

Status: COMPLETED

Clinical Research Site

Houston, Texas 77030 - United States

Status: WITHDRAWN

Clinical Research Site

Fairfax, Virginia 22031 - United States

Status: RECRUITING

Clinical Research Site

Edegem, Antwerp 2650 - Belgium

Status: TERMINATED

And 8 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Hepatic Impairment, Advanced Malignant Solid Tumor:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships